1. Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma. (9th June 2019) Authors: Spurgeon, Stephen E.; Sharma, Kamal; Claxton, David F.; Ehmann, Christopher; Pu, Jeffrey; Shimko, Sara; Stewart, August; Subbiah, Nan; Palmbach, Gundula; LeBlanc, Francis; Latour, Emile; Chen, YiYi; Mori, Motomi; Hasanali, Zainul; Epner, Elliot M. Journal: British journal of haematology Issue: Volume 186:Number 6(2019) Page Start: 845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗